
|Articles|July 1, 2002
Topical shows persistence
Los Angeles - Preliminary results from a split-face, double-blind study are further substantiating the efficacy of a unique topical product containing growth factors and antioxidants for improving photodamaged skin and indicate that its effects persist and increase even after treatment is stopped, Richard E. Fitzpatrick, M.D., reported at the annual meeting of the Society for Investigative Dermatology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
2
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
3
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
4
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
5











